ArTS Archivio della ricerca di Trieste

PORCARI, ALDOSTEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.613
AS - Asia 5.570
EU - Europa 4.933
SA - Sud America 752
AF - Africa 139
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.029
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.410
IT - Italia 2.240
SG - Singapore 1.998
CN - Cina 1.260
BR - Brasile 590
HK - Hong Kong 535
VN - Vietnam 511
DE - Germania 443
KR - Corea 387
FR - Francia 324
BD - Bangladesh 317
FI - Finlandia 267
NL - Olanda 263
GB - Regno Unito 260
SE - Svezia 248
PL - Polonia 177
RU - Federazione Russa 177
IN - India 137
CH - Svizzera 96
CA - Canada 93
JP - Giappone 80
IE - Irlanda 71
AT - Austria 68
BG - Bulgaria 67
TR - Turchia 61
AR - Argentina 60
MX - Messico 56
MA - Marocco 45
ES - Italia 42
ID - Indonesia 35
IQ - Iraq 32
UA - Ucraina 31
SA - Arabia Saudita 26
ZA - Sudafrica 25
CO - Colombia 24
CZ - Repubblica Ceca 24
BE - Belgio 23
EC - Ecuador 19
EG - Egitto 19
PK - Pakistan 18
VE - Venezuela 17
CL - Cile 16
IR - Iran 16
AU - Australia 14
RO - Romania 14
TW - Taiwan 14
AE - Emirati Arabi Uniti 13
GR - Grecia 11
IL - Israele 11
JO - Giordania 11
LT - Lituania 11
MY - Malesia 11
PE - Perù 11
TH - Thailandia 10
UZ - Uzbekistan 10
DZ - Algeria 9
NO - Norvegia 9
OM - Oman 9
PH - Filippine 9
PT - Portogallo 9
KE - Kenya 8
PA - Panama 8
BY - Bielorussia 7
CR - Costa Rica 7
ET - Etiopia 7
HU - Ungheria 7
KZ - Kazakistan 7
SI - Slovenia 7
SK - Slovacchia (Repubblica Slovacca) 7
BO - Bolivia 5
DO - Repubblica Dominicana 5
GE - Georgia 5
JM - Giamaica 5
KG - Kirghizistan 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
SN - Senegal 5
UY - Uruguay 5
AL - Albania 4
AO - Angola 4
AZ - Azerbaigian 4
DK - Danimarca 4
GT - Guatemala 4
HR - Croazia 4
NP - Nepal 4
PY - Paraguay 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
CU - Cuba 3
GA - Gabon 3
KH - Cambogia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
LV - Lettonia 3
MM - Myanmar 3
MU - Mauritius 3
SM - San Marino 3
AM - Armenia 2
BB - Barbados 2
Totale 16.978
Salva come PNG Salva come JPEG
Città #
Singapore 1.108
Ashburn 860
San Jose 620
Hong Kong 517
Hefei 496
Seoul 382
Chandler 363
Trieste 283
Council Bluffs 271
Milan 236
Beijing 222
Helsinki 205
Boardman 197
Los Angeles 167
Ho Chi Minh City 164
Munich 163
Dallas 159
Chicago 151
Fairfield 143
Rome 133
New York 118
Santa Clara 116
Hanoi 115
Lauterbourg 110
London 102
Zgierz 102
Columbus 94
Seattle 84
Houston 74
Moscow 73
Frankfurt am Main 72
Bern 71
Dublin 71
Wilmington 69
Woodbridge 67
Naples 65
The Dalles 65
São Paulo 64
Buffalo 63
Sofia 63
Princeton 56
Cambridge 53
Warsaw 52
Nuremberg 44
Vienna 43
Turin 42
Tokyo 38
Lappeenranta 36
Florence 35
Orem 34
Amsterdam 32
Montreal 32
Redondo Beach 32
Casablanca 29
Da Nang 29
Shanghai 29
Washington 29
Ann Arbor 28
Paris 28
Atlanta 27
Denver 27
Brooklyn 26
Chennai 26
Toronto 26
Udine 25
Phoenix 24
Jacksonville 23
Venice 23
Verona 23
Bologna 22
Memphis 22
Düsseldorf 21
Mumbai 20
Palermo 20
Turku 20
Bari 19
Boydton 19
Istanbul 19
Padova 19
Belo Horizonte 18
Genoa 18
Parma 18
Stockholm 18
Venezia 18
Izmir 17
Brussels 15
Haiphong 15
Karlsruhe 15
Roubaix 15
Boston 14
Catania 14
Charlotte 14
Manchester 14
Barnet 13
Biên Hòa 13
Brasília 13
Bremen 13
Brescia 13
Guangzhou 13
Madrid 13
Totale 9.964
Salva come PNG Salva come JPEG
Nome #
Iperpotassiemia nello scompenso cardiaco: nuove soluzioni per un vecchio problema 547
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 408
I dieci punti che il cardiologo deve conoscere su scintigrafia miocardica con traccianti ossei, amiloidosi e cuore 370
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients 310
Cardiac amyloidosis: a changing epidemiology with open challenges 289
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 287
Clinical validation of a coronary surgery technique that minimizes aortic manipulation 267
Characterization of Cardiac Function by Echocardiographic Global Longitudinal Strain in a Cohort of Children with Neurofibromatosis Type 1 Treated with Selumetinib 260
Cardiac Tumors: Diagnosis, Prognosis, and Treatment 258
Terapia di modulazione della contrattilità cardiaca: basi molecolari e razionale per l’impiego in modelli di insufficienza cardiaca sistolica e diastolica 254
Cardiovascular aging: the unveiled enigma from bench to bedside 244
Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF 237
Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle 233
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 210
The fate of patients having deep sternal infection after bilateral internal thoracic artery grafting in the negative pressure wound therapy era 207
Acute inflammatory cardiomyopathy: apparent neutral prognostic impact of immunosuppressive therapy 199
Cardiac magnetic resonance abnormalities in patients with acute myocarditis proven by septal endomyocardial biopsy 195
Clinical application of cardiac scintigraphy with bone tracers: controversies and pitfalls in cardiac amyloidosis 194
Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques 192
Miocarditi, pericarditi e vaccino a mRNA contro il COVID-19. Expert opinion della Società Italiana di Cardiologia 187
Sex differences in natural history of cardiovascular magnetic resonance- and biopsy-proven lymphocytic myocarditis 187
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies 183
Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study 183
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 180
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 178
Radiologia cardiovascolare. 70 anni di immagini dall’“Archivio Camerini” ai giorni nostri 172
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 170
The (ultra) sound of a burning heart: A matter of speckles 170
Myocarditis: Which Role for Genetics? 170
Breakthrough advances enhancing care in ATTR amyloid cardiomyopathy 169
Endomyocardial biopsy in the clinical context: current indications and challenging scenarios 167
Grey zones in the supportive treatments of cardiac amyloidosis 166
Tafamidis in the Treatment of ATTR-related Cardiomyopathy: Indications and Grey Zones 165
Post-discharge arrhythmic risk stratification of patients with acute myocarditis and life-threatening ventricular tachyarrhythmias 163
Diagnosi e cura dell’amiloidosi cardiaca in Italia: risultati della survey della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 161
A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentation 160
Viral presence-guided immunomodulation in lymphocytic myocarditis: an update 160
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 159
Validation and Performance Comparison of Two Scoring Systems Created Specifically to Predict the Risk of Deep Sternal Wound Infection after Bilateral Internal Thoracic Artery Grafting 159
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 153
The alcohol-induced cardiomyopathy: A cardiovascular magnetic resonance characterization 152
Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors 152
Cardiac Magnetic Resonance in Primary Prevention of Sudden Cardiac Death 150
Clinical Use of Biomarkers in Cardiac Amyloidosis 149
Cardiac transplantation in transthyretin amyloid cardiomyopathy: Outcomes from three decades of tertiary center experience 149
The American College of Cardology/American Heart Association Heart Failure Staging System Highlights Diagnostic Delay and Predicts Outcome in Transthyretin Cardiac Amyloidosis 147
Cardiac amyloidosis: do not forget to look for it 146
Prognostic significance of unexplained left ventricular hypertrophy in patients undergoing carpal tunnel surgery 146
Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination 144
Che cos’è l’Amiloidosi? 143
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 138
Re-Definition of the Epidemiology of Cardiac Amyloidosis 135
Pericardiectomy for constrictive pericarditis: a risk factor analysis for early and late failure 135
The Arrhythmic Phenotype in Cardiomyopathy 134
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 134
Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importance 129
Lung damage in SARS-CoV-2 patients: An autopsy study in the era of vaccination 126
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 122
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 122
Razionale e valore fondamentale della Rete Italiana integrata dell’Amiloidosi Cardiaca 120
Editorial for the article: Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the Veneto Region, Italy 116
Restrictive cardiomyopathy: definition and diagnosis 114
Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis 112
Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy 112
Transthyretin cardiac amyloidosis 112
Cardiac Amyloidosis 111
Dieci possibili linee future di ricerca e innovazione nell’amiloidosi cardiaca 111
New perspectives in diagnosis and risk stratification of non-ischaemic dilated cardiomyopathy 110
Light-chain cardiac amyloidosis: a case report of extraordinary sustained pathological response to cyclophosphamide, bortezomib, and dexamethasone combined therapy 109
Trends in age and sex-specific dilated cardiomyopathy mortality in Italy, 2005-2017 107
Myocardial perfusion in cardiac amyloidosis 105
Specific Therapy in Transthyretin Amyloid Cardiomyopathy: Future Perspectives Beyond Tafamidis 105
One-Year Risk of myocarditis after COVID-19 infection: a systematic review and meta-analysis 104
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years 104
Precision medicine in heart failure no longer a visual theory but a realistic opportunity 103
Atrial electro-functional predictors of incident atrial fibrillation in cardiac amyloidosis 103
Impact of the Noninvasive Diagnostic Algorithm on Clinical Presentation and Prognosis in Cardiac Amyloidosis 101
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey 101
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis 100
Standardizing the role of endomyocardial biopsy in current clinical practice worldwide 100
Update 2022 dell’Expert Opinion della Società Italiana di Cardiologia su miocarditi, pericarditi e vaccini contro il COVID-19 100
Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis 100
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy 99
Cardiac amyloidosis: when to suspect and how to confirm 98
Lights and Shadows of Clinical Applications of Cardiac Scintigraphy with Bone Tracers in Suspected Amyloidosis 98
Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 96
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 93
Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery 92
Prognostic impact of hypertension and diabetes in patients with cardiac amyloidosis 89
Patologie acute del pericardio 89
Comparison of 99mTc-DPD Scintigraphy, CMR Imaging, and Echocardiography in Patients With V30M-Associated Hereditary Transthyretin Amyloidosis 89
Management of hypertrophic cardiomyopathy 88
Tracking Treatment Response in Cardiac Light-Chain Amyloidosis with Native T1 Mapping 88
Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis 87
Final farewell to Claudio Rapezzi: observation, deduction and knowledge in medicine 86
Conventional heart failure therapy in cardiac ATTR amyloidosis 86
Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations 84
Modulazione della contrattilità cardiaca nello scompenso cardiaco a frazione di eiezione ridotta: revisione critica delle evidenze ed aspetti decisionali pratici 82
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration 82
Filling the gap in epidemiology, management and clinical course of COVID-19 vaccination-related pericarditis 82
Totale 15.444
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.503
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 0 0 38
2021/2022538 28 35 47 28 31 42 34 31 67 37 63 95
2022/20231.357 72 161 152 192 106 188 35 122 159 35 90 45
2023/20241.844 164 92 97 146 138 145 265 235 44 98 213 207
2024/20253.867 136 178 381 303 330 273 286 244 403 555 329 449
2025/20269.034 699 619 712 759 620 754 1.137 375 1.060 1.093 720 486
Totale 17.454